Ubs Group Ag Astrazeneca PLC Put Options Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Put Options

25 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$76.67 - $87.62 $5.93 Million - $6.78 Million
-77,400 Reduced 43.63%
100,000 $7.79 Million
Q2 2024

Aug 13, 2024
SELL
$66.81 - $80.83 $6.85 Million - $8.29 Million
-102,600 Reduced 36.64%
177,400 $13.8 Million
Q1 2024

May 13, 2024
BUY
$61.03 - $69.57 $9.22 Million - $10.5 Million
151,100 Added 117.22%
280,000 $19 Million
Q3 2023

Nov 09, 2023
SELL
$64.85 - $71.7 $24.2 Million - $26.8 Million
-373,200 Reduced 74.33%
128,900 $8.73 Million
Q2 2023

Aug 11, 2023
BUY
$69.91 - $75.81 $167,784 - $181,944
2,400 Added 0.48%
502,100 $35.9 Million
Q1 2023

May 12, 2023
BUY
$63.15 - $71.6 $31.2 Million - $35.4 Million
494,000 Added 8666.67%
499,700 $34.7 Million
Q3 2022

Nov 10, 2022
BUY
$53.02 - $135.75 $53,020 - $135,750
1,000 Added 21.28%
5,700 $313,000
Q2 2022

Aug 10, 2022
SELL
$59.26 - $71.14 $12.4 Million - $14.9 Million
-210,000 Reduced 97.81%
4,700 $311,000
Q1 2022

May 16, 2022
BUY
$55.72 - $67.12 $10.9 Million - $13.1 Million
195,000 Added 989.85%
214,700 $14.2 Million
Q2 2021

Aug 13, 2021
BUY
$48.42 - $60.18 $726,300 - $902,700
15,000 Added 319.15%
19,700 $1.18 Million
Q1 2021

May 12, 2021
SELL
$47.16 - $54.44 $42,444 - $48,996
-900 Reduced 16.07%
4,700 $234,000
Q3 2020

Nov 12, 2020
BUY
$53.07 - $61.1 $84,912 - $97,760
1,600 Added 40.0%
5,600 $307,000
Q2 2020

Jul 31, 2020
BUY
$43.1 - $55.31 $137,920 - $176,992
3,200 Added 400.0%
4,000 $212,000
Q1 2020

May 01, 2020
SELL
$37.79 - $51.33 $7,558 - $10,266
-200 Reduced 20.0%
800 $36,000
Q3 2019

Nov 14, 2019
SELL
$40.12 - $45.47 $1.29 Million - $1.46 Million
-32,200 Reduced 96.99%
1,000 $45,000
Q2 2019

Aug 14, 2019
SELL
$37.28 - $41.68 $2.18 Million - $2.43 Million
-58,400 Reduced 63.76%
33,200 $1.37 Million
Q1 2019

May 14, 2019
BUY
$35.49 - $43.02 $1.57 Million - $1.91 Million
44,300 Added 93.66%
91,600 $3.7 Million
Q4 2018

Feb 14, 2019
BUY
$36.86 - $41.49 $33,174 - $37,341
900 Added 1.94%
47,300 $1.8 Million
Q3 2018

Nov 14, 2018
SELL
$34.76 - $39.72 $340,648 - $389,256
-9,800 Reduced 17.44%
46,400 $1.84 Million
Q2 2018

Aug 14, 2018
BUY
$34.55 - $37.05 $245,304 - $263,055
7,100 Added 14.46%
56,200 $1.97 Million
Q1 2018

May 15, 2018
SELL
$32.97 - $36.63 $2.04 Million - $2.27 Million
-62,000 Reduced 55.81%
49,100 $1.72 Million
Q4 2017

Feb 14, 2018
BUY
$32.09 - $34.78 $147,614 - $159,988
4,600 Added 4.32%
111,100 $3.86 Million
Q3 2017

Nov 14, 2017
BUY
$28.96 - $34.0 $909,344 - $1.07 Million
31,400 Added 41.81%
106,500 $3.61 Million
Q2 2017

Aug 14, 2017
BUY
N/A
1,600 Added 2.18%
75,100 $2.56 Million
Q1 2017

Nov 14, 2017
BUY
N/A
73,500
73,500 $2.29 Million

Others Institutions Holding AZN

# of Institutions
1,359
Shares Held
475M
Call Options Held
5.39M
Put Options Held
3.75M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email